AIM: To evaluate the performance of a neurologic assessment protocol among jaundiced infants requiring exchange transfusion (ET). METHODS: We identified infants in a referral children's hospital who received ET and those who met the American Academy of Pediatrics (AAP) criteria for ET based on total serum bilirubin (TSB) levels. The performance of a bilirubin-induced neurologic dysfunction (BIND-M) scoring protocol for acute bilirubin encephalopathy (ABE) in detecting infants treated with ET in both groups was investigated by logistic regression analysis and c-statistic. RESULTS: A total of 438 late-preterm and term infants were enrolled, out of which 141 (32.2%) received ET, and 155 (35.4%) met AAP criteria for ET. Infants with BIND-M scores of 3-6 (intermediate ABE) or 7-12 (advanced ABE) were significantly associated with ET in both groups, but not scores of 1-2 (mild ABE), with or without adjustment for confounding neurotoxicity risk factors. However, the discriminatory ability of BIND-M regression models was modestly satisfactory (c-statistic range: 0.693-0.791). CONCLUSIONS: Our findings suggest that BIND-M is a potentially useful decision-making tool for ET and support current recommendation for immediate ET for infants with intermediate-to-advanced stages of ABE regardless of the TSB levels.
AIM: To evaluate the performance of a neurologic assessment protocol among jaundicedinfants requiring exchange transfusion (ET). METHODS: We identified infants in a referral children's hospital who received ET and those who met the American Academy of Pediatrics (AAP) criteria for ET based on total serum bilirubin (TSB) levels. The performance of a bilirubin-induced neurologic dysfunction (BIND-M) scoring protocol for acute bilirubinencephalopathy (ABE) in detecting infants treated with ET in both groups was investigated by logistic regression analysis and c-statistic. RESULTS: A total of 438 late-preterm and term infants were enrolled, out of which 141 (32.2%) received ET, and 155 (35.4%) met AAP criteria for ET. Infants with BIND-M scores of 3-6 (intermediate ABE) or 7-12 (advanced ABE) were significantly associated with ET in both groups, but not scores of 1-2 (mild ABE), with or without adjustment for confounding neurotoxicity risk factors. However, the discriminatory ability of BIND-M regression models was modestly satisfactory (c-statistic range: 0.693-0.791). CONCLUSIONS: Our findings suggest that BIND-M is a potentially useful decision-making tool for ET and support current recommendation for immediate ET for infants with intermediate-to-advanced stages of ABE regardless of the TSB levels.
Entities:
Keywords:
Acute bilirubin encephalopathy; exchange transfusion; late presentation; neurological examination; newborn care
Authors: R McGready; J Simpson; S Panyavudhikrai; S Loo; E Mercuri; L Haataja; T Kolatat; F Nosten; L Dubowitz Journal: Ann Trop Paediatr Date: 2000-12
Authors: Kay M Tomashek; Chadd J Crouse; Solomon Iyasu; Christopher H Johnson; Lisa M Flowers Journal: Paediatr Perinat Epidemiol Date: 2006-01 Impact factor: 3.980
Authors: Rasha Gamaleldin; Iman Iskander; Iman Seoud; Hanan Aboraya; Aleksandr Aravkin; Paul D Sampson; Richard P Wennberg Journal: Pediatrics Date: 2011-09-12 Impact factor: 7.124
Authors: Bolajoko O Olusanya; Tinuade A Ogunlesi; Praveen Kumar; Nem-Yun Boo; Iman F Iskander; Maria Fernanda B de Almeida; Yvonne E Vaucher; Tina M Slusher Journal: BMC Pediatr Date: 2015-04-12 Impact factor: 2.125